We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$204M
AUM Growth
+$15.9M
Cap. Flow
+$17.5M
Cap. Flow %
8.58%
Top 10 Hldgs %
6.14%
Holding
488
New
66
Increased
245
Reduced
135
Closed
40

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$976K
2
NFLX icon
Netflix
NFLX
+$953K
3
CRWD icon
CrowdStrike
CRWD
+$952K
4
RCL icon
Royal Caribbean
RCL
+$905K
5
TJX icon
TJX Companies
TJX
+$890K

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$1.11M
2
LLY icon
Eli Lilly
LLY
+$937K
3
FCX icon
Freeport-McMoran
FCX
+$933K
4
ALGN icon
Align Technology
ALGN
+$933K
5
MLM icon
Martin Marietta Materials
MLM
+$930K

Sector Composition

Rank Sector Weight
1 Financials 26.66%
2 Healthcare 19.14%
3 Technology 17.16%
4 Energy 7.21%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SID icon
326
Companhia Siderúrgica Nacional
SID
$1.49B
$128K 0.06%
55,610
+7,054
+15% +$18.6K
LBPH
327
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$123K 0.06%
+4,538
New +$89.5K
NRIX icon
328
Nurix Therapeutics
NRIX
$2.43B
$113K 0.06%
5,411
-4,282
-44% -$66.7K
MORF
329
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$111K 0.05%
3,262
+327
+11% +$9.69K
IRON icon
330
Disc Medicine
IRON
$2.85B
$104K 0.05%
2,312
+824
+55% +$28K
ERAS icon
331
Erasca
ERAS
$6.55B
$98K 0.05%
+41,526
New +$89.6K
EXAI
332
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$97K 0.05%
19,018
+4,334
+30% +$21.4K
CELC icon
333
Celcuity
CELC
$4.01B
$96.7K 0.05%
+5,901
New +$98.7K
ELVN icon
334
Enliven Therapeutics
ELVN
$3.77B
$96.1K 0.05%
+4,111
New +$86.5K
DNLI icon
335
Denali Therapeutics
DNLI
$3.74B
$95K 0.05%
4,092
+357
+10% +$6.85K
DYN icon
336
Dyne Therapeutics
DYN
$4.24B
$94.8K 0.05%
2,687
-4,639
-63% -$135K
AGEN
337
Agenus
AGEN
$255M
$94.8K 0.05%
5,658
-33
-0.6% -$399
BHVN icon
338
Biohaven
BHVN
$2.18B
$94.1K 0.05%
2,710
+407
+18% +$16.1K
PHVS icon
339
Pharvaris
PHVS
$2.37B
$94K 0.05%
+5,001
New +$102K
ANAB icon
340
AnaptysBio
ANAB
$1.59B
$93.5K 0.05%
3,733
-818
-18% -$19K
PRAX icon
341
Praxis Precision Medicines
PRAX
$8.8B
$93.5K 0.05%
+2,260
New +$107K
MLTX icon
342
MoonLake Immunotherapeutics
MLTX
$1.66B
$93.2K 0.05%
2,120
+616
+41% +$26.1K
CYTK icon
343
Cytokinetics
CYTK
$10.9B
$93K 0.05%
1,717
-650
-27% -$39.2K
MRUS
344
DELISTED
Merus
MRUS
$92.9K 0.05%
1,570
-1,861
-54% -$90.1K
XENE icon
345
Xenon Pharmaceuticals
XENE
$6.36B
$92.8K 0.05%
2,380
+277
+13% +$11.1K
TNGX icon
346
Tango Therapeutics
TNGX
$4.35B
$92.6K 0.05%
10,790
+2,288
+27% +$17.7K
RNAM
347
DELISTED
Avidity Biosciences
RNAM
$92.5K 0.05%
2,265
-8,524
-79% -$245K
PCVX icon
348
Vaxcyte
PCVX
$8.01B
$92.3K 0.05%
1,223
-209
-15% -$14.2K
VKTX icon
349
Viking Therapeutics
VKTX
$4.05B
$92.1K 0.05%
1,738
-2,773
-61% -$182K
CLDX icon
350
Celldex Therapeutics
CLDX
$2.8B
$92K 0.05%
2,485
+86
+4% +$3.25K
12 13
14
15 16

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, Virtus ETF Advisers held 488 positions worth $204M, up 8.5% from $188M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers deployed $17.5M of net new capital in Q2 2024, opening 66 new positions and adding to 245 existing holdings. Its largest new stake was Qualcomm: 5,165 shares worth $1.03M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Extra Space Storage, an estimated $732K trimmed.

  • Virtus ETF Advisers's largest Q2 2024 buy was Qualcomm: 5,165 shares worth $1.03M.
  • Virtus ETF Advisers added most to EOG Resources in Q2 2024, an estimated $789K increase.
  • Virtus ETF Advisers's biggest Q2 2024 reduction was Extra Space Storage, cutting an estimated $732K.
  • Virtus ETF Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.11M.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $204M portfolio in Q2 2024.
  • Virtus ETF Advisers opened 66 new positions and closed 40 in Q2 2024.
  • Virtus ETF Advisers's portfolio value rose 8.5% quarter-over-quarter to $204M.

Based on Virtus ETF Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.